drugset / Trial / NCT06017037

REward Processing And Citalopram Study

NCT06017037

Phase 1/2 Unknown 40 enrolled University of Oxford
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this experimental medicine study is to examine the effect of increasing serotonin on reward processing in healthy volunteers. The main questions it aims to answer are: 1. Does a subacute increase in serotonin influence the activation regions during reward learning 2. Does a subacute increase in serotonin influence behavioural markers of reward valuation (effort task), responsiveness (taste task) and learning (learning task) Participants will be: given a 7-day course of the selective serotonin reuptake inhibitor, citalopram. undergo behavioural testing complete a reward learning task whilst undergoing fMRI Researchers will compare results against a placebo group.

Timeline

Start
2023-05-19
Primary completion
2024-05-01
Completion
2024-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg Oral